Glaxo Operations UK Limited
UkraineAll drugs from this manufacturer
-
The drug is used for maintenance therapy to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Dosage form: powder, inhalation, metered
Active substance Dosage umeclidinium 55 mcg vilanterol 22 mcg ATC: R03AL03
-
The drug is used for the symptomatic treatment of allergic rhinitis.
Dosage form: spray, nasal suspension
Active substance Dosage fluticasone furoate 27.5 mcg ATC: R01AD12
-
The drug is used for the topical treatment of bacterial skin infections, such as impetigo, folliculitis, and furunculosis.
Dosage form: ointment
Active substance Dosage mupirocin 20 mg/g ATC: D06AX09
-
The drug is used for the topical treatment of nasal cavity infections caused by Staphylococcus aureus, including methicillin-resistant strains.
Dosage form: ointment, nasal
Active substance Dosage mupirocin 20 mg/g ATC: D06AX09
-
The drug is used for the topical treatment of mild to moderate acne vulgaris, primarily when inflammatory elements are present. It can be used by adults and children from 12 years of age.
Dosage form: gel
Active substance Dosage benzoyl peroxide 50 mg clindamycin 10 mg ATC: D10AF51
-
The drug is prescribed for the regular treatment of asthma in adults and children aged 12 years and older, if standard treatment methods do not provide adequate disease control, or to maintain adequate status in cases of already established control.
Dosage form: powder, inhalation, metered
Active substance Dosage fluticasone furoate 184 mcg/dose vilanterol 22 mcg per dose ATC: R03AK10
-
The drug is used for the regular treatment of asthma in adults and children from 12 years of age, as well as for the symptomatic treatment of adults with chronic obstructive pulmonary disease (COPD).
Dosage form: powder, inhalation, metered
Active substance Dosage fluticasone furoate 92 mcg per dose vilanterol 22 mcg per dose ATC: R03AK10
-
The drug is intended for the short-term treatment of severe manifestations of HIV infection in patients with AIDS who are unable to take oral tablets. It is also used for pregnant women (after 14 weeks of pregnancy) and newborns to prevent mother-to-child transmission of the virus.
Dosage form: solution for infusion
Active substance Dosage zidovudine 10 mg/ml ATC: J05AF01
-
The drug is used to treat many infections in adults and children from 3 months of age, including acute tonsillitis, pharyngitis, bacterial sinusitis, otitis, exacerbation of chronic bronchitis, cystitis, pyelonephritis, skin infections, and early manifestations of Lyme disease.
Dosage form: powder for oral suspension
Active substance Dosage cefuroxime 125 mg/5 ml ATC: J01DC02
-
The drug is used to treat many infections in adults and children aged 3 months and older, specifically acute tonsillitis, pharyngitis, sinusitis, otitis, exacerbations of chronic bronchitis, cystitis, pyelonephritis, skin infections, and early manifestations of Lyme disease.
Dosage form: tablets, film-coated
Active substance Dosage cefuroxime 125 mg ATC: J01DC02
-
The drug is used to treat various infections in adults and children aged 3 months and older, including acute tonsillitis, pharyngitis, sinusitis, otitis, exacerbation of chronic bronchitis, cystitis, pyelonephritis, skin infections, and early manifestations of Lyme disease.
Dosage form: tablets, film-coated
Active substance Dosage cefuroxime 250 mg ATC: J01DC02
-
The drug is used to treat many infections in adults and children aged 3 months and older, specifically acute tonsillitis, pharyngitis, sinusitis, otitis, exacerbation of chronic bronchitis, cystitis, pyelonephritis, skin infections, and early manifestations of Lyme disease.
Dosage form: tablets, film-coated
Active substance Dosage cefuroxime 500 mg ATC: J01DC02